TrialPanorama/TrialPanorama-database huggingface dataset:
Study 7528307 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 21969009 — Surrogate Endpoint (SUR): Blood pressure
Study 14522567 — Surrogate Endpoint (SUR): Blood pressure
Study 11033843 — Safety Biomarker (SAF): Interleukin 12
Study 8604676 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 24103327 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study 24103327 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 17051503 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 12626886 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 11340106 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 19096190 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17073160 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 1547763 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study 18667204 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 18667204 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18667204 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 1542832 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 25412591 — Surrogate Endpoint (SUR): Blood pressure
Study 24222839 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 24222839 — Surrogate Endpoint (SUR): Blood pressure
Study 21695122 — Predictive Biomarker (PRD): MC3R mRNA
Genes: MC3R
Study 19323633 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 28263383 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 23245993 — Predictive Biomarker (PRD): LAMA1 mRNA
Genes: LAMA1; LAMA
Study 14688498 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 6852623 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 27189284 — Surrogate Endpoint (SUR): Bone mineral density
Study 16262540 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 7200319 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7200319 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 27773929 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 25411289 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22464779 — Monitoring Biomarker (MOI): HBV DNA
Study 28689524 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 8723171 — Surrogate Endpoint (SUR): Blood pressure
Study 1362887 — Surrogate Endpoint (SUR): Blood pressure
Study 27676396 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 27676396 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 10771458 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 8610920 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 8610920 — Predictive Biomarker (PRD): Hormone receptor
Study 22930241 — Surrogate Endpoint (SUR): Bone mineral density
Study 16178478 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 16178478 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16178478 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 16178478 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 1782724 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP
Study 25123447 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 25123447 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22621970 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 17585221 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25738481 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 25738481 — Surrogate Endpoint (SUR): Blood pressure
Study 16433809 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 31587660 — Surrogate Endpoint (SUR): Blood pressure
Study 29151562 — Surrogate Endpoint (SUR): Blood pressure
Study 26447154 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 26447154 — Safety Biomarker (SAF): IL-6 and IL-10
Study 26447154 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 20054593 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study 20001868 — Surrogate Endpoint (SUR): Bone mineral density
Study 12897584 — Surrogate Endpoint (SUR): Blood pressure
Study 31421395 — Surrogate Endpoint (SUR): Bone mineral density
Study 31421395 — Surrogate Endpoint (SUR): Serum calcium
Study 24383513 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 24383513 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 24383513 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 24383513 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 22608580 — Surrogate Endpoint (SUR): Forced vital capacity
Study 8570775 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study 31838255 — Surrogate Endpoint (SUR): Blood pressure
Study 24613110 — Predictive Biomarker (PRD): IL11
Genes: IL-11; AGIF
Study 23241457 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 30607578 — Predictive Biomarker (PRD): CEBPA mRNA
Genes: CEBPA; CEBP
Study 30258440 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 30258440 — Predictive Biomarker (PRD): C5AR2 mRNA
Genes: C5AR2; C5L2; GPR77
Study 16447880 — Predictive Biomarker (PRD): LPO mRNA
Genes: LPO; SAPX
Study 16447880 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 16447880 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 22499292 — Surrogate Endpoint (SUR): Blood pressure
Study 15083634 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15083634 — Surrogate Endpoint (SUR): Blood pressure
Study 8058230 — Surrogate Endpoint (SUR): Blood pressure
Study 19691545 — Surrogate Endpoint (SUR): Blood pressure
Study 7741071 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 1970298 — Surrogate Endpoint (SUR): Blood pressure
Study 18570696 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 9825504 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 26475583 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-210
Genes: MIR210
Study 26475583 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-21
Genes: MIR21
Study 26475583 — Safety Biomarker (SAF): miR-146a
Genes: MIR146A
Study 26475583 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-150
Genes: MIR150
Study 28526538 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 23921483 — Surrogate Endpoint (SUR): Serum triglycerides
Study 11724442 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 18822909 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 10710206 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 9347091 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 24504006 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 3058374 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study 3058374 — Surrogate Endpoint (SUR): Serum triglycerides
Study 23044732 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study 15292101 — Surrogate Endpoint (SUR): Serum testosterone
Study 29956042 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 24549094 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 24549094 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 24549094 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 24549094 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 24549094 — Safety Biomarker (SAF): IL-6 and IL-10
Study 20229199 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study 20229199 — Surrogate Endpoint (SUR): Serum calcium
Study 9312717 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 25299079 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 23097240 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 15976803 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 16816943 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study 19067473 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study 19067473 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 19067473 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 12230933 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 27061921 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study 2187665 — Surrogate Endpoint (SUR): Blood pressure
Study 31801154 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 1805295 — Predictive Biomarker (PRD): PBX1 mRNA
Genes: PBX1; PRL
Study 6137975 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TNS1 mRNA
Genes: TNS1; TNS
Study 22252342 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 12364554 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 7485222 — Surrogate Endpoint (SUR): Serum creatinine
Study 28745470 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 28745470 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 28745470 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 18784962 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 15785958 — Surrogate Endpoint (SUR): Blood pressure
Study 19101780 — Surrogate Endpoint (SUR): Blood pressure
Study 15237752 — Predictive Biomarker (PRD): LTA mRNA
Genes: LTA; TNFB; TNFSF1
Study 3370020 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 3370020 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 331853 — Surrogate Endpoint (SUR): Serum triglycerides
Study 22345687 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 22345687 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 20501476 — Predictive Biomarker (PRD): GPI mRNA
Genes: GPI
Study 2478015 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 11035338 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 22908105 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 2102136 — Surrogate Endpoint (SUR): Blood pressure
Study 30668853 — Predictive Biomarker (PRD): Hormone receptor
Study 27582421 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 15650862 — Surrogate Endpoint (SUR): Blood pressure
Study 12764910 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 12764910 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study 12764910 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 10496553 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19664956 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 12526189 — Surrogate Endpoint (SUR): Bone mineral density
Study 12526189 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 579342 — Surrogate Endpoint (SUR): Blood pressure
Study 21888655 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 28994675 — Surrogate Endpoint (SUR): Serum creatinine
Study 26870843 — Surrogate Endpoint (SUR): Probing pocket depth
Study 25134117 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 15010730 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 23299850 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study 18461102 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18461102 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 12932675 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 12932675 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study 12932675 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 10867980 — Surrogate Endpoint (SUR): Blood pressure
Study 26547540 — Surrogate Endpoint (SUR): Blood pressure
Study 31368284 — Predictive Biomarker (PRD): SP6 mRNA
Genes: SP6; KLF14
Study 29456025 — Surrogate Endpoint (SUR): Blood pressure
Study 18797179 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 8635184 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 25976647 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study 17083064 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 26757045 — Predictive Biomarker (PRD): DPT mRNA
Genes: DPT
Study 11879139 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 31860326 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study 31860326 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 31860326 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 29974963 — Predictive Biomarker (PRD): FCER1G mRNA
Genes: FCER1G
Study 29974963 — Predictive Biomarker (PRD): C3AR1 mRNA
Genes: C3AR1; AZ3B; C3R1; HNFAG09
Study 29974963 — Predictive Biomarker (PRD): CD93 mRNA
Genes: CD93; C1QR1; MXRA4
Study 29974963 — Predictive Biomarker (PRD): S100A8 mRNA
Genes: S100A8; CAGA; CFAG; MRP8
Study 29974963 — Predictive Biomarker (PRD): Calgranulin B
Genes: S100A9; CAGB; CFAG; MRP14
Study 29974963 — Safety Biomarker (SAF): Cellular communication network factor 1
Genes: CCN1; CYR61; GIG1; IGFBP10
Study 29974963 — Predictive Biomarker (PRD): KRT6A mRNA
Genes: KRT6A; K6A; KRT6D
Study 29974963 — Predictive Biomarker (PRD): KRT16 mRNA
Genes: KRT16; KRT16A
Study 19848209 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 19848209 — Surrogate Endpoint (SUR): Blood pressure
Study 17489878 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17489878 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 17489878 — Surrogate Endpoint (SUR): Blood pressure
Study 11506246 — Surrogate Endpoint (SUR): Blood pressure
Study 11506246 — Surrogate Endpoint (SUR): Serum creatinine
Study 21325901 — Surrogate Endpoint (SUR): Blood pressure
Study 16433203 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 16433203 — Predictive Biomarker (PRD): MPL mRNA
Genes: MPL; TPOR
Study 9950912 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 9950912 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 25310201 — Surrogate Endpoint (SUR): Blood pressure
Study 18508832 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 16141467 — Safety Biomarker (SAF): Reactive oxygen species
Study 8656257 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 22692126 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 22692126 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 19663098 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 9892527 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 21364482 — Predictive Biomarker (PRD): C6 mRNA
Genes: C6
Study 18634158 — Surrogate Endpoint (SUR): Bone mineral density
Study 16926664 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 16926664 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 28065179 — Surrogate Endpoint (SUR): Blood pressure
Study 21664779 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study 21664779 — Predictive Biomarker (PRD): DHPS mRNA
Genes: DHPS; DS
Study 11838838 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 7573902 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 30955702 — Predictive Biomarker (PRD): MCCC2 mRNA
Genes: MCCC2; MCCB
Study 8046277 — Predictive Biomarker (PRD): TH mRNA
Genes: TH; TYH
Study 8046277 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 22749044 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 20053144 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 16319156 — Safety Biomarker (SAF): Hyaluronic acid
Study 12873934 — Surrogate Endpoint (SUR): Blood pressure
Study 8879439 — Predictive Biomarker (PRD): VLDLR mRNA
Genes: VLDLR
Study 8879439 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 8879439 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 30026562 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21788129 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 11011783 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 6626636 — Pharmacodynamic Biomarker (PDY): Mismatch negativity
Study 25856221 — Surrogate Endpoint (SUR): Bone mineral density
Study 22817664 — Surrogate Endpoint (SUR): Bone mineral density
Study 21059637 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study 31548792 — Surrogate Endpoint (SUR): Blood pressure
Study 3534849 — Surrogate Endpoint (SUR): Blood pressure
Study 17272491 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17272491 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 17272491 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 7800307 — Surrogate Endpoint (SUR): Blood pressure
Study 25179314 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 25179314 — Surrogate Endpoint (SUR): Blood pressure
Study 15363822 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 15363822 — Surrogate Endpoint (SUR): Blood pressure
Study 7846213 — Predictive Biomarker (PRD): SLC10A3 mRNA
Genes: SLC10A3; DXS253E; P3
Study 1328579 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 26859081 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 12455714 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 12455714 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 10600428 — Surrogate Endpoint (SUR): Blood pressure
Study 8530573 — Pharmacodynamic Biomarker (PDY): Amyloid beta peptide (1-40)
Genes: APP; A4; AD1
Study 17488375 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 9585802 — Surrogate Endpoint (SUR): Blood pressure
Study 31941795 — Predictive Biomarker (PRD): RYR1 mRNA
Genes: RYR1; RYDR
Study 31941795 — Safety Biomarker (SAF): RYR1
Genes: RYR; PPP1R137
Study 30604381 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 27998971 — Predictive Biomarker (PRD): DEPDC1 mRNA
Genes: DEPDC1; DEPDC1A
Study 27998971 — Predictive Biomarker (PRD): KIF20B mRNA
Genes: KIF20B; KRMP1; MPHOSPH1
Study 27998971 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study 27050101 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 15665022 — Pharmacodynamic Biomarker (PDY): Insulin receptor substrate 1
Genes: IRS1
Study 9658743 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 23541163 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 21806766 — Surrogate Endpoint (SUR): Blood pressure
Study 12074361 — Surrogate Endpoint (SUR): Blood pressure
Study 12074361 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12074361 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 10434217 — Surrogate Endpoint (SUR): Blood pressure
Study 31673875 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study 31673875 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 31673875 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 22418831 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study 14529932 — Predictive Biomarker (PRD): C2 mRNA
Genes: C2
Study 14529932 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 11796432 — Predictive Biomarker (PRD): FEV mRNA
Genes: FEV; PET1
Study 10232690 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 16926249 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 16926249 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 8506477 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 24871654 — Surrogate Endpoint (SUR): Blood pressure
Study 22545932 — Surrogate Endpoint (SUR): Blood pressure
Study 22545932 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 18444867 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 18444867 — Surrogate Endpoint (SUR): Serum creatinine
Study 11976156 — Surrogate Endpoint (SUR): Blood pressure
Study 11318787 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 27379793 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 27410176 — Pharmacodynamic Biomarker (PDY): Mitochondrial membrane potential
Study 12773061 — Predictive Biomarker (PRD): EPX mRNA
Genes: EPX; EPER; EPO; EPP